Phantom test procedures for a new neuro-oncological amino acid PET tracer: [18F]fluciclovine

被引:0
作者
Tsuzura, Kaede [1 ]
Wagatsuma, Kei [2 ,3 ]
Kamitaka, Yuto [3 ]
Miwa, Kenta [4 ]
Miyaji, Noriaki [4 ]
Kamiya, Takashi [1 ]
Yokotsuka, Noriyo [5 ]
Ishii, Kenji [3 ]
机构
[1] Osaka Univ Hosp, Dept Med Technol, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Kitasato Univ, Sch Allied Hlth Sci, 1-15-1 Kitazato,Minami Ku, Sagamihara, Kanagawa 2520373, Japan
[3] Tokyo Metropolitan Inst Geriatr & Gerontol, Res Team Neuroimaging, 35-2 Sakae Cho,Itabashi Ku, Tokyo 1730015, Japan
[4] Fukushima Med Univ, Sch Hlth Sci, Dept Radiol Sci, 10-6 Sakaemachi, Fukushima, Fukushima 9608516, Japan
[5] Teikyo Univ, Fac Med Technol, Dept Radiol Technol, 2-11-1 Kaga,Itabashi Ku, Tokyo 1738605, Japan
关键词
Amino acid; Glioma; Neuro-oncology; Quantitative evaluation; Standardization; POSITRON-EMISSION-TOMOGRAPHY; BRAIN-TUMORS; C-11-METHIONINE; ARTIFACTS;
D O I
10.1007/s12149-024-01973-x
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: Amino acid positron emission tomography (PET) examinations using anti-1-amino-3-[F-18]-fluorocyclobutane-1-carboxylic acid ([F-18]FACBC) were allowed for routine clinical use in July 2024. However, phantom test procedures for [F-18]FACBC reconstruction parameters have not yet been established. The present study aimed to establish new phantom test procedures for [F-18]FACBC brain PET imaging to determine optimal reconstruction parameters. Methods: Background (BG) activity as well as hot sphere and target-to-background ratios (TBRs) of [F-18]FACBC were estimated based on brain activity and tumor-to-normal tissue ratios (TNR) in a Japanese clinical trial of [F-18]FACBC. Phantom experiments proceeded under [F-18]FACBC or L-[methyl-C-11]-methionine ([C-11]MET) conditions. The number of iterations and the Gaussian filter parameters were determined from the reconstruction parameters %contrast(mean) and coefficients of variation (CVs) in ordered subset expectation maximization (OSEM) and time-of-flight (TOF) with or without point-spread-function (PSF) correction. Results: The amounts of activity in the hot spheres and BG were 1.1 and 5.5 kBq/mL, respectively, and the TBR was 5.0 at the start of acquisition. The %contrast(mean) of all hot spheres was higher with [F-18]FACBC than [C-11]MET, and %contrast(mean) converged between 4 and 6 iterations in hot spheres with diameters < 10 mm. We used four iterations for OSEM + TOF and five for OSEM + TOF + PSF correction for [F-18]FACBC and [C-11]MET images. The CV was higher for [F-18]FACBC than [C-11]MET. The optimal sizes of Gaussian filters for OSEM + TOF and OSEM + TOF + PSF correction of image reconstruction were 5 mm for [F-18]FACBC, and 4 and 3 mm, respectively, for [C-11]MET images. Conclusions: We estimated phantom activity and TBR based on brain activity in a Japanese clinical trial and established new phantom test procedures for [F-18]FACBC. We recommend that the optimal reconstruction parameters for [F-18]FACBC should be set to the same number of iterations as [C-11]MET and that the FWHM of Gaussian filter should have a few mm higher than [C-11]MET to reduce image noise from brain normal tissue.
引用
收藏
页码:21 / 30
页数:10
相关论文
共 40 条
  • [11] Diagnostic accuracy of anti-3-[18F]-FACBC PET/MRI in gliomas
    Karlberg, Anna
    Pedersen, Lars Kjelsberg
    Vindstad, Benedikte Emilie
    Skjulsvik, Anne Jarstein
    Johansen, Hakon
    Solheim, Ole
    Skogen, Karoline
    Kvistad, Kjell Arne
    Bogsrud, Trond Velde
    Myrmel, Kristin Smistad
    Giskeodegard, Guro F.
    Ingebrigtsen, Tor
    Berntsen, Erik Magnus
    Eikenes, Live
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (02) : 496 - 509
  • [12] Multimodal 18F-Fluciclovine PET/MRI and Ultrasound-Guided Neurosurgery of an Anaplastic Oligodendroglioma
    Karlberg, Anna
    Berntsen, Erik Magnus
    Johansen, Hakon
    Myrthue, Mariane
    Skjulsvik, Anne Jarstein
    Reinertsen, Ingerid
    Esmaeili, Morteza
    Dai, Hong Yan
    Xiao, Yiming
    Rivaz, Hassan
    Borghammer, Per
    Solheim, Ole
    Eikenes, Live
    [J]. WORLD NEUROSURGERY, 2017, 108 : 989.e1 - 989.e8
  • [13] Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors
    Kondo, Akihide
    Ishii, Hisato
    Aoki, Shigeki
    Suzuki, Masaru
    Nagasawa, Hidekazu
    Kubota, Kazuo
    Minamimoto, Ryogo
    Arakawa, Atsushi
    Tominaga, Masato
    Arai, Hajime
    [J]. ANNALS OF NUCLEAR MEDICINE, 2016, 30 (09) : 608 - 618
  • [14] Delineation of brain tumor extent with [11C]L-methionine positron emission tomography:: Local comparison with stereotactic histopathology
    Kracht, LW
    Miletic, H
    Busch, S
    Jacobs, AH
    Voges, J
    Hoevels, M
    Klein, JC
    Herholz, K
    Heiss, WD
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (21) : 7163 - 7170
  • [15] From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology
    Kubota, K
    [J]. ANNALS OF NUCLEAR MEDICINE, 2001, 15 (06) : 471 - 486
  • [16] Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
    Law, Ian
    Albert, Nathalie L.
    Arbizu, Javier
    Boellaard, Ronald
    Drzezga, Alexander
    Galldiks, Norbert
    la Fougere, Christian
    Langen, Karl-Josef
    Lopci, Egesta
    Lowe, Val
    McConathy, Jonathan
    Quick, Harald H.
    Sattler, Bernhard
    Schuster, David M.
    Tonn, Joerg-Christian
    Weller, Michael
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) : 540 - 557
  • [17] 18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors
    Michaud, Laure
    Beattie, B. J.
    Akhurst, T.
    Dunphy, M.
    Zanzonico, P.
    Finn, R.
    Mauguen, A.
    Schoder, H.
    Weber, W. A.
    Lassman, A. B.
    Blasberg, R.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (06) : 1353 - 1367
  • [18] Impact of γ factor in the penalty function of Bayesian penalized likelihood reconstruction (Q.Clear) to achieve high-resolution PET images
    Miwa, Kenta
    Yoshii, Tokiya
    Wagatsuma, Kei
    Nezu, Shogo
    Kamitaka, Yuto
    Yamao, Tensho
    Kobayashi, Rinya
    Fukuda, Shohei
    Yakushiji, Yu
    Miyaji, Noriaki
    Ishii, Kenji
    [J]. EJNMMI PHYSICS, 2023, 10 (01)
  • [19] Detection of sub-centimeter lesions using digital TOF-PET/CT system combined with Bayesian penalized likelihood reconstruction algorithm
    Miwa, Kenta
    Wagatsuma, Kei
    Nemoto, Reo
    Masubuchi, Masaki
    Kamitaka, Yuto
    Yamao, Tensho
    Hiratsuka, Seiya
    Yamaguchi, Masashi
    Yoshii, Tokiya
    Kobayashi, Rinya
    Miyaji, Noriaki
    Ishii, Kenji
    [J]. ANNALS OF NUCLEAR MEDICINE, 2020, 34 (10) : 762 - 771
  • [20] Evaluation of scatter limitation correction: a new method of correcting photopenic artifacts caused by patient motion during whole-body PET/CT imaging
    Miwa, Kenta
    Umeda, Takuro
    Murata, Taisuke
    Wagatsuma, Kei
    Miyaji, Noriaki
    Terauchi, Takashi
    Koizumi, Mitsuru
    Sasaki, Masayuki
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (02) : 147 - 154